Natalie Dean

Natalie E. Dean (née Exner; born 1987) is an American biostatistician specializing in infectious disease epidemiology. Dean is currently an assistant professor of Biostatistics at the University of Florida. Her research involves epidemiological modeling of outbreaks, including Ebola, Zika and COVID-19. Provided by Wikipedia
Showing 1 - 10 results of 10 for search 'Natalie E. Dean', query time: 0.04s Refine Results
  1. 1
    Hypothesis testing and sample size considerations for the test-negative design

    Hypothesis testing and sample size considerations for the test-negative design by Yanan Huo, Yang Yang, M. Elizabeth Halloran, Ira M. Longini, Natalie E. Dean

    Published 2024-07-01
    Get full text
    Article
  2. 2
    Analysis methods for covariate-constrained cluster randomized trials with time-to-event outcomes

    Analysis methods for covariate-constrained cluster randomized trials with time-to-event outcomes by Amy M. Crisp, M. Elizabeth Halloran, Matt D. T. Hitchings, Ira M. Longini, Natalie E. Dean

    Published 2025-01-01
    Get full text
    Article
  3. 3
    Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants

    Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants by Zachary J. Madewell, Yang Yang, Ira M. Longini, M. Elizabeth Halloran, Alessandro Vespignani, Natalie E. Dean

    Published 2023-06-01
    Get full text
    Article
  4. 4
    Model-based estimates of chikungunya epidemiological parameters and outbreak risk from varied data types

    Model-based estimates of chikungunya epidemiological parameters and outbreak risk from varied data types by Alexander D. Meyer, Sandra Mendoza Guerrero, Natalie E. Dean, Kathryn B. Anderson, Steven T. Stoddard, T. Alex Perkins

    Published 2023-12-01
    Get full text
    Article
  5. 5
    Estimating the impact of COVID-19 vaccine inequities: a modeling study

    Estimating the impact of COVID-19 vaccine inequities: a modeling study by Nicolò Gozzi, Matteo Chinazzi, Natalie E. Dean, Ira M. Longini Jr, M. Elizabeth Halloran, Nicola Perra, Alessandro Vespignani

    Published 2023-06-01
    Get full text
    Article
  6. 6
    Effectiveness of the fourth dose of COVID-19 vaccines against severe COVID-19 among adults 40 years or older in Brazil: a population-based cohort studyResearch in context

    Effectiveness of the fourth dose of COVID-19 vaccines against severe COVID-19 among adults 40 years or older in Brazil: a population-based cohort studyResearch in context by Felippe Lazar Neto, Matt D.T. Hitchings, Avnika B. Amin, Giovanny V.A. de França, Margaret L. Lind, Mario Sergio Scaramuzzini Torres, Daniel Henrique Tsuha, Roberto D. de Oliveira, Derek A.T. Cummings, Natalie E. Dean, Jason R. Andrews, Albert I. Ko, Julio Croda, Otavio T. Ranzani

    Published 2024-06-01
    Get full text
    Article
  7. 7
    Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative case-control analysis.

    Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative case-con... by Margaret L Lind, Alexander J Robertson, Julio Silva, Frederick Warner, Andreas C Coppi, Nathan Price, Chelsea Duckwall, Peri Sosensky, Erendira C Di Giuseppe, Ryan Borg, Mariam O Fofana, Otavio T Ranzani, Natalie E Dean, Jason R Andrews, Julio Croda, Akiko Iwasaki, Derek A T Cummings, Albert I Ko, Matt D T Hitchings, Wade L Schulz

    Published 2022-12-01
    Get full text
    Article
  8. 8
    Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative case–control analysis

    Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative case–con... by Margaret L. Lind, Alexander J. Robertson, Julio Silva, Frederick Warner, Andreas C. Coppi, Nathan Price, Chelsea Duckwall, Peri Sosensky, Erendira C. Di Giuseppe, Ryan Borg, Mariam O. Fofana, Otavio T. Ranzani, Natalie E. Dean, Jason R. Andrews, Julio Croda, Akiko Iwasaki, Derek A. T. Cummings, Albert I. Ko, Matt D. T. Hitchings, Wade L. Schulz

    Published 2022-12-01
    Get full text
    Article
  9. 9
    Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil

    Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil by Otavio T. Ranzani, Matt D. T. Hitchings, Rosana Leite de Melo, Giovanny V. A. de França, Cássia de Fátima R. Fernandes, Margaret L. Lind, Mario Sergio Scaramuzzini Torres, Daniel Henrique Tsuha, Leticia C. S. David, Rodrigo F. C. Said, Maria Almiron, Roberto D. de Oliveira, Derek A. T. Cummings, Natalie E. Dean, Jason R. Andrews, Albert I. Ko, Julio Croda

    Published 2022-10-01
    Get full text
    Article
  10. 10
    Observational research in epidemic settings: a roadmap to reform

    Observational research in epidemic settings: a roadmap to reform by Marc Lipsitch, Nicholas Evans, Alexandra L Phelan, Stephany N Duda, Annette Rid, Colin J Carlson, Jennifer B Rosen, Natalie E Dean, John Barugahare, Maya B Mathur, Emily E Ricotta, Fausto A Bustos Carrillo, Samuel Angelli-Nichols, Adia Benton, Emma Chang-Rabley, Lisa Federer, Mary-Margaret A Fill, Elizabeth C LeRoy, Natalie M Linton, Lauren Sauer, Sheena G Sullivan, Mackenzie Zendt

    Published 2025-02-01
    Get full text
    Article

Search Tools: